Product Overview
ID Components Size (96 tests)
ISK-016-1 High-bind Plate 1 plate
ISK-016-2 Human IL-4 R alpha 30 μg
ISK-016-3 Human IL-4 20 μg
ISK-016-4 Human IL-4-Biotin 10 μg
ISK-016-5 Streptavidin-HRP 10 μg
ISK-016-6 Coating Buffer 12 mL
ISK-016-7 10xWashing Buffer 50 mL
ISK-016-8 Blocking Buffer 50 mL
ISK-016-9 Substrate Solution 12 mL
ISK-016-10 Stop Solution 7 mL
Description
Interleukin-4, is a cytokine that induces differentiation of naive helper T cells (Th0 cells to Th2 cells). In the presence of IL-4 and IL-13, cytokines that are produced in a Th-2 type response, particularly during allergy and parasitic infections, macrophages become differentially activated, And this cytokine is a ligand for interleukin 4 receptor. The interleukin 4 receptor also binds to IL13, which may contribute to many overlapping functions of this cytokine and IL13. STAT6, a signal transducer and activator of transcription, has been shown to play a central role in mediating the immune regulatory signal of this cytokine.
Assay Principles
This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new IL-4 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human IL-4 to immobilized human IL-4 R alpha in a functional ELISA assay, and employs a simple colorimetric sandwich ELISA platform.
Your experiment will include 4 simple steps:
a) Coat the plate with human IL-4 R alpha.
b) Add your molecule of interest to the tests.
c) Add human IL-4-Biotin to bind the coated human IL-4 R alpha.
d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.
Finally, the ability of your compound to inhibit IL-4: IL-4 R alpha Rbinding will be determined by comparing OD readings among different experimental groups.